课题基金 / 基金详情

Louisiana Clinical and Translational Science Center Planning Phase

Louisiana Clinical and Translational Science Center Planning Phase
路易斯安那州临床和转化科学中心规划阶段
批准号:
7216075
负责人:
Donna Harrington Ryan
金额:
$24.4万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-22 至 2008-09-21

项目摘要

项目成果

Donna Harrington Ryan的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供):路易斯安那州临床和转化科学中心(LA CaTS中心)的规划是由路易斯安那州立大学(LSD)系统的三个机构(LSU A&M,路易斯安那州立大学新奥尔良健康科学中心(LSUHSC NO)和彭宁顿生物医学研究中心(PBRC)承担的一项倡议。计划阶段将为提交临床转化科学奖(CTSA)申请奠定基础。申请机构和规划工作的领导者是PBRC,临床和转化研究的典范,并坚定地致力于改善该地区临床和转化研究人员的环境。规划阶段将汇集临床和转化生物医学研究、研究管理和研究生教育方面的关键领导人,以便对洛杉矶CaTS中心的内容、治理、管理和评估进行规划,并管理实施该计划所需的必要的组织和文化变革。规划阶段还允许通过网站和在新奥尔良、什里夫波特和巴吞鲁日举行的会议就这一过程进行沟通,以鼓励全州的支持和参与。洛杉矶CaTS中心的长期愿景是吸引全州的临床和转化研究人员,洛杉矶CaTS中心作为一个平台,为路易斯安那州的转化研究人员提供研究资源。洛杉矶CaTS中心将扩大临床和转化研究基地,并有助于促进新奥尔良临床研究的重生。发展洛杉矶CaTS中心的过程预计需要三个阶段:规划、启动和推广。洛杉矶CaTS中心的愿景不仅是在现有水平上扩大研究基地,而且要提高临床研究的效率和速度。由于卡特里娜飓风破坏了临床和转化研究以及研究生教育基础设施,目前非常需要这种努力。洛杉矶CaTS中心将开发创新的多学科研究生教育项目,其目标是通过在学科界面的多个领域培养个人来推进发现。除了为路易斯安那州提供服务外,洛杉矶CaTS中心还将作为孵化器,促进创新工具和信息技术的发展,使该领域受益。
英文摘要
DESCRIPTION (provided by applicant): The planning of the Louisiana Clinical and Translational Science Center (LA CaTS Center) is an initiative undertaken by three institutions of the Louisiana State University (LSD) System (LSU A&M, LSU Health Sciences Center in New Orleans (LSUHSC NO) and the Pennington Biomedical Research Center (PBRC).The planning phase will lay the foundation for the submission of a Clinical Translational Science Award (CTSA) application. The applicant institution and leader of the planning effort is PBRC, a model of clinical and translational research and strongly committed to advancing the enviroment for clinical and translational researchers in the region. The Planning Phase will serve to assemble key leaders in clinical and translational biomedical research, in research administration and in graduate education in order to plan for the content, governance, administration and evaluation of the LA CaTS Center and to manage the necessary organizational and cultural changes needed to implement the program. The planning phase also allows for communication about the process via a website and at meetings in New Orleans, Shreveport and Baton Rouge, so as to encourage support and involvement across the state. The long term vision for the LA CaTS Center is to engage clinical and translational researchers throughout the state, with the LA CaTS Center serving as a platform to supply research resources to translational researchers throughout Louisiana. The LA CaTS Center will expand the clinical and translational research base, and can help foster the rebirth of clinical research in New Orleans. The process for developing the LA CaTS Center is projected to require three phases: Planning, Start-up and Outreach. The vision for the LA CaTS Center is not only to expand the research base from existing levels, but also to improve efficiency and speed of clinical research. This effort is greatly needed at this time due to the disruption of the clinical and translational research and graduate education infrastructure by Hurricane Katrina. The LA CaTS Center will develop innovative multidisciplinary graduate education programs with a goal of advancing discovery by training individuals in multiple areas at the interface of disciplines. In addition to activities serving Louisiana, the LA CaTS Center will serve as an incubator to foster the development of innovative tools and information technologies that can benefit the field.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
One-pot synthesis of 1,4-dihydroxy-2-((E)-1-hydroxy-4-phenylbut-3-enyl)anthracene-9,10-diones as novel shikonin analogs and evaluation of their antiproliferative activities.
新型紫草素类似物1,4-二羟基-2-((E)-1-羟基-4-苯基丁-3-烯基)蒽-9,10-二酮的一锅合成及其抗增殖活性评价。
DOI: 10.1016/j.bmcl.2016.04.006
发表时间: 2016
期刊: Bioorganic & medicinal chemistry letters
影响因子: 2.7
作者: [Zhao,Li-Ming, Cao,Feng-Xia, Jin,Hai-Shan, Zhang,Jie-Huan, Szwaya,Jeffrey, Wang,Guangdi]
通讯作者: Wang,Guangdi
Louisiana Clinical and Translational Science Center
LOUISIANA CLINICAL AND TRANSLATIONAL SCIENCE CENTER PLANNING PHASE